Genomatica Awarded $750,000 Phase II SBIR Grant from Department of Energy for enhancing SimPheny™, a software platform for systems biology

Genomatica, Inc., a leading in silico systems biology company, announced today it has received a Phase II Small Business Innovation Research (SBIR) Grant from the U.S. Department of Energy (DOE) under their Genomics: GtL Program. The two year award for approximately $750,000 will be used to enhance core components of SimPheny™, the company’s flagship software platform. These enhancements will expand SimPheny’s ability to support collaborative research efforts at leading academic and commercial institutions focused on metabolic research.

Please to read the entire article.

You must be logged in to post a comment Login